As of 2024-12-12, the EV/EBITDA ratio of Pila Pharma AB (PILA.ST) is -17.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PILA.ST's latest enterprise value is 104.06 mil SEK. PILA.ST's TTM EBITDA according to its financial statements is -5.80 mil SEK. Dividing these 2 quantities gives us the above PILA.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-12-10 | -17.95 |
| 2024-12-09 | -18.28 |
| 2024-12-06 | -18.32 |
| 2024-12-05 | -18.51 |
| 2024-12-04 | -18.65 |
| 2024-12-03 | -18.88 |
| 2024-12-02 | -18.04 |
| 2024-11-29 | -18.56 |
| 2024-11-28 | -18.46 |
| 2024-11-27 | -19.12 |
| 2024-11-26 | -19.07 |
| 2024-11-25 | -19.21 |
| 2024-11-22 | -20.99 |
| 2024-11-21 | -20.29 |
| 2024-11-20 | -20.19 |
| 2024-11-19 | -19.21 |
| 2024-11-18 | -20.52 |
| 2024-11-15 | -21.08 |
| 2024-11-14 | -22.72 |
| 2024-11-13 | -19.07 |
| 2024-11-12 | -18.93 |
| 2024-11-11 | -20.71 |
| 2024-11-08 | -21.65 |
| 2024-11-07 | -21.55 |
| 2024-11-06 | -21.41 |
| 2024-11-05 | -22.02 |
| 2024-11-04 | -22.77 |
| 2024-11-01 | -23.42 |
| 2024-10-31 | -22.72 |
| 2024-10-30 | -22.86 |
| 2024-10-29 | -23.42 |
| 2024-10-28 | -23.42 |
| 2024-10-25 | -23.05 |
| 2024-10-24 | -22.91 |
| 2024-10-23 | -23.42 |
| 2024-10-22 | -22.67 |
| 2024-10-21 | -23.52 |
| 2024-10-18 | -22.96 |
| 2024-10-17 | -23.52 |
| 2024-10-16 | -24.64 |
| 2024-10-15 | -26.14 |
| 2024-10-14 | -25.67 |
| 2024-10-11 | -24.73 |
| 2024-10-10 | -23.52 |
| 2024-10-09 | -24.36 |
| 2024-10-08 | -24.92 |
| 2024-10-07 | -24.17 |
| 2024-10-04 | -24.83 |
| 2024-10-03 | -26.32 |
| 2024-10-02 | -26.89 |